Liquidia Corp (LQDA)
12.80
+0.01
(+0.08%)
USD |
NASDAQ |
May 06, 09:50
Liquidia Gross Profit (Quarterly): 3.538M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.538M |
September 30, 2023 | 3.108M |
June 30, 2023 | 4.115M |
March 31, 2023 | 3.839M |
December 31, 2022 | 4.666M |
September 30, 2022 | 2.425M |
June 30, 2022 | 3.187M |
March 31, 2022 | 2.798M |
December 31, 2021 | 2.489M |
September 30, 2021 | 2.289M |
June 30, 2021 | 2.662M |
March 31, 2021 | 2.39M |
December 31, 2020 | 0.5019M |
September 30, 2020 | 0.00 |
Date | Value |
---|---|
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 7.265M |
March 31, 2019 | |
December 31, 2018 | 0.5684M |
September 30, 2018 | 0.1697M |
June 30, 2018 | 0.9485M |
March 31, 2018 | 0.8989M |
December 31, 2017 | 1.736M |
September 30, 2017 | 1.741M |
June 30, 2017 | 1.902M |
March 31, 2017 | 1.559M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2019
7.265M
Maximum
Jun 2019
2.383M
Average
2.489M
Median
Dec 2021
Gross Profit (Quarterly) Benchmarks
United Therapeutics Corp | 604.80M |
AIM ImmunoTech Inc | 0.053M |
Perspective Therapeutics Inc | -- |
Protalix BioTherapeutics Inc | 1.63M |
Armata Pharmaceuticals Inc | -- |